News Focus
News Focus
icon url

hweb2

03/23/22 10:58 AM

#96132 RE: 2morrowsGains #96124

Nice pop on ELTK. Strong backlog for 2022 sounds positive and I like the balance sheet & low float. But the Q4 bottom line excluding the tax benefit was pretty anemic. Would have only been a few pennies per share. So seems fairly valued in the $4's. Will check the CC transcript later to see if anything of note on there.

https://finance.yahoo.com/news/eltek-reports-full-fourth-quarter-113000368.html
icon url

hweb2

04/04/22 12:06 PM

#96391 RE: 2morrowsGains #96124

Picking up some ELTK with the crazy run CPSH has been on in recent days after getting pumped as a defense play. ELTK only earned a few pennies in Q4 before the tax benefit (hey that's better earnings than CPSH ha). But ELTK has a great balance sheet with $1.58/share in cash, an easy Q1 comp on the way, a healthy backlog increase and a low float.

Saw this in the 20-F filing-

Our backlog at December 31, 2021 was approximately $10.0 million compared to a backlog of approximately $6.8 million at December 31, 2020. We include in our backlog all purchase orders scheduled for delivery within the next 12 months.

And that doesn't include the $1.4M defense order ELTK announced in February. Probably why they were quite bullish during the CC on 3/23/22. This CC quote from the CEO seems to bode well for the coming quarters-

"As for the current situation, in Europe, we believe that governments will increase their spending on military project, which will positively reflect our revenue about 50% of our revenue are defense and aerospace-related. During the fourth quarter of 2021 and the beginning of 2022, our book-to-sell ratio increased significantly, which result in strong backlog. Therefore, we have decided to accelerate our planned capital investment and to try to implement them in a period of two years instead of five years. We are also investing a lot of efforts in recruiting new employees."